Martin Sima (Martin Šíma, M Šíma)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 36

Top Venues

Pharmaceutics

Clinical and translational science

Antibiotics (Basel, Switzerland)

Journal of chemotherapy (Florence, Italy)

First faculty of Medicine, Charles University in Prague (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

First faculty of Medicine, Charles University in Prague Oct 01 2012 - Oct 19 2017

Czechia

PHD

Publications

Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Lucie Polášková, Jan Miroslav Hartinger, Irena Murínová, Pavel Michálek, Ondrej Slanar, Martin Sima
Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model. Journal of chemotherapy (Florence, Italy) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Sara Merdita, Martin Sima, Jan Dvořák, Martin Matějů, Igor Richter, Petr Kozlík, Tomáš Křížek, Jana Královičová, Jan Bosák, Luboš Petruželka, Ondřej Slanař
Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model. British journal of clinical pharmacology (2024)
Eliška Dvořáčková, Martin Sima, Andrea Zajacová, Kristýna Vyskočilová, Tereza Kotowski, Kateřina Dunovská, Eva Klapková, Jan Havlín, Robert Lischke, Ondrej Slanar
Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Martin Sima, Ondrej Slanar
Dose Optimization and Targeting Strategies of Anti-Infective Agents. Pharmaceutics 15 (7) (2023)
Jiří Hofmann, Aleš Bartůněk, Tomáš Hauser, Gregor Sedmak, Josef Beránek, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans. Leukemia (2023)
Karel Urbánek, Petr Šantavý, Ondřej Zuščich, Vendula Kubíčková, Danica Michaličková, Ondřej Slanař, Martin Sima
Population pharmacokinetic model-based dosing proposal for ampicillin prophylaxis in cardiac surgery patients with cardiopulmonary bypass. Journal of chemotherapy (Florence, Italy) (2023)
Eliska Dvorackova, Martin Sima, Kristyna Vyskocilova, Tereza Kotowski, Kateřina Dunovská, Eva Klapkova, Jan Havlin, Robert Lischke, Ondrej Slanar
Population pharmacokinetics and covariate-based dosing individualization of voriconazole in lung transplant recipients. Journal of chemotherapy (Florence, Italy) (2023)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Eliška Dvořáčková, Martin Sima, Jakub Petrus, Eva Klapková, Petr Hubáček, Jiří Pozniak, Jan Havlín, Robert Lischke, Ondrej Slanar
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics 14 (2) (2022)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, David Řezáč, Jan Hlaváč, Ondřej Slanař, Martin Sima
Meropenem population pharmacokinetics and model-based dosing optimisation in patients with serious bacterial infection. European journal of hospital pharmacy : science and practice (2022)
Alzbeta Zavrelova, Martin Sima, Jana Malakova, Petra Rozsivalova, Pavla Paterova, Pavel Zak, Benjamin Visek, Danica Michalickova, Ondrej Slanar, Jakub Radocha
Superiority of ceftazidime off-label high-dose regimen in PK/PD target attainment during treatment of extensively drug resistant Pseudomonas aeruginosa infections in cancer patients. British journal of clinical pharmacology (2022)
Martina Kodetova, Radka Hobzova, Jakub Sirc, Jiri Uhlik, Katerina Dunovska, Karel Svojgr, Ana-Irina Cocarta, Andrea Felsoova, Ondrej Slanar, Martin Sima, Igor Kozak, Pavel Pochop
The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant. Pharmaceutics 14 (5) (2022)
Jana Královičová, Aleš Bartůněk, Jiří Hofmann, Tomáš Křížek, Petr Kozlík, Jaroslava Roušarová, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs. Pharmaceutics 14 (3) (2022)
Petr Šantavý, Martin Sima, Ondřej Zuščich, Vendula Kubíčková, Danica Michaličková, Ondřej Slanař, Karel Urbánek
Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Petr Jelínek, Jaroslava Roušarová, Pavel Ryšánek, Martina Ježková, Tereza Havlůjová, Jiří Pozniak, Petr Kozlík, Tomáš Křížek, Tomáš Kučera, Martin Sima, Ondřej Slanař, Miroslav Soos
Application of Oil-in-Water Cannabidiol Emulsion for the Treatment of Rheumatoid Arthritis. Cannabis and cannabinoid research (2022)
Martin Sima, Daniel Bobek, Petra Cihlářová, Pavel Ryšánek, Jaroslava Roušarová, Jan Beroušek, Martin Kuchar, Tomáš Vymazal, Ondrej Slanar
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics 14 (8) (2022)
Jan Miroslav Hartinger, Pavel Ryšánek, Ondřej Slanař, Martin Sima
Pharmacokinetic principles of dose adjustment of mTOR inhibitors in solid organ transplanted patients. Journal of clinical pharmacy and therapeutics 47 (9) (2022)
Jan Miroslav Hartinger, Martin Sima, Karolína Hronová, Barbora Agátha Halouzková, Barbora Szonowská, Vladimír Polakovič, Vladimíra Bednářová, Zuzana Hladinová, Vladimír Tesař, Ondřej Slanař
Vancomycin pharmacokinetics in patients treated with intermittent haemodialysis based on therapeutic drug monitoring. Journal of chemotherapy (Florence, Italy) (2021)
Martin Sima, Danica Michaličková, Ondřej Slanař
What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates? Pharmaceutics 13 (3) (2021)
Pavel Ryšánek, Tomáš Grus, Peter Lukáč, Petr Kozlík, Tomáš Křížek, Jiří Pozniak, Jaroslava Roušarová, Jana Královičová, Nikolina Kutinová Canová, Tereza Boleslavská, Jan Bosák, František Štěpánek, Martin Sima, Ondřej Slanař
Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs. British journal of pharmacology 178 (23) (2021)
Martin Sima, Danica Michaličková, Pavel Ryšánek, Petra Cihlářová, Martin Kuchař, Daniela Lžičařová, Jan Beroušek, Jan Miroslav Hartinger, Tomáš Vymazal, Ondřej Slanař
No Time Dependence of Ciprofloxacin Pharmacokinetics in Critically Ill Adults: Comparison of Individual and Population Analyses. Pharmaceutics 13 (8) (2021)
Pavla Pokorná, Martin Sima, Natálie Švestková, Ondřej Slanař
Levetiracetam pharmacokinetics and its covariates: proprosal for optimal dosing in the paediatric population. European journal of hospital pharmacy : science and practice (2021)
Martin Sima, Ondřej Slanař
Impact of drug-drug interactions on phenobarbital pharmacokinetics in pediatric patients. Epilepsia 60 (6) (2020)
Pavla Pokorná, Martin Sima, Dick Tibboel, Ondřej Slanař
Impact of haemolysis on vancomycin disposition in a full-term neonate treated with extracorporeal membrane oxygenation. Perfusion 36 (8) (2020)
Jan Matek, Stanislav Cernohorsky, Stanislav Trca, Zdenek Krska, David Hoskovec, Jan Bruthans, Martin Sima, Pavel Michálek
A Randomized Comparison of Plasma Levobupivacaine Concentrations Following Thoracic Epidural Analgesia and Subpleural Paravertebral Analgesia in Open Thoracic Surgery. Journal of clinical medicine 9 (5) (2020)
Ondřej Slanař, Karolína Hronová, Olga Bartošová, Martin Sima
Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics. Expert opinion on drug metabolism & toxicology 17 (3) (2020)
Pavla Pokorná, Martin Sima, Václav Vobruba, Martina Bašková, Lenka Posch, Ondřej Slanař
Sufentanil pharmacokinetics in a full-term neonate treated with extracorporeal membrane oxygenation: a case report. Perfusion 34 (5) (2019)
Martin Sima, Jan Hartinger, Tomáš Grus, Ondřej Slanař
Initial dosing of intermittent vancomycin in adults: estimation of dosing interval in relation to dose and renal function. European journal of hospital pharmacy : science and practice 28 (5) (2019)
Pavla Pokorná, Martin Sima, Václav Vobruba, Dick Tibboel, Ondřej Slanař
Phenobarbital pharmacokinetics in neonates and infants during extracorporeal membrane oxygenation. Perfusion 33 (1_suppl) (2018)
Martin Sima, Martin Vodička, Věra Marešová, Tomáš Šálek, Radomír Čabala, Ondřej Slanař
Adherence with perindopril therapy: a pilot study using therapeutic drug monitoring of perindoprilat and an evaluation of the clearance estimation. International journal of clinical pharmacy 39 (5) (2017)
O Bartošová, C Bonnet, Olga Ulmanová, Martin Sima, F Perlík, Evžen Růžička, Ondrej Slanar
Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients. Journal of neural transmission (Vienna, Austria : 1996) 125 (4) (2017)

Martin Sima.css-eqlu8i{font-size:small;padding-left:4px;} (Martin Šíma, M Šíma)

Publication Activity (10 Years)

Top Topics

Top Venues

Martin Sima (Martin Šíma, M Šíma)